Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts NMRA Hot Sheet
Join SI Premium – FREE
Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q2 EPS of ($0.33), $0.12 better than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Names Top Electrical Equipment Stocks Ahead of Earnings Season
- Goldman Sachs Downgrades Albertsons Companies Inc. (ACI) to Neutral
- EnerSys names Navi Grewal as chief digital and AI officer
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
